449 related articles for article (PubMed ID: 27096956)
1. Predictive microRNAs for lymph node metastasis in endoscopically resectable submucosal colorectal cancer.
Jung CK; Jung SH; Yim SH; Jung JH; Choi HJ; Kang WK; Park SW; Oh ST; Kim JG; Lee SH; Chung YJ
Oncotarget; 2016 May; 7(22):32902-15. PubMed ID: 27096956
[TBL] [Abstract][Full Text] [Related]
2. A Liquid Biopsy Assay for Noninvasive Identification of Lymph Node Metastases in T1 Colorectal Cancer.
Wada Y; Shimada M; Murano T; Takamaru H; Morine Y; Ikemoto T; Saito Y; Balaguer F; Bujanda L; Pellise M; Kato K; Saito Y; Ikematsu H; Goel A
Gastroenterology; 2021 Jul; 161(1):151-162.e1. PubMed ID: 33819484
[TBL] [Abstract][Full Text] [Related]
3. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer.
Chen X; Wang YW; Zhu WJ; Li Y; Liu L; Yin G; Gao P
Hum Pathol; 2018 Jun; 76():122-132. PubMed ID: 29555574
[TBL] [Abstract][Full Text] [Related]
4. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
[TBL] [Abstract][Full Text] [Related]
5. Early metastatic colorectal cancers show increased tissue expression of miR-17/92 cluster members in the invasive tumor front.
Jepsen RK; Novotny GW; Klarskov LL; Bang-Berthelsen CH; Haakansson IT; Hansen A; Christensen IJ; Riis LB; Høgdall E
Hum Pathol; 2018 Oct; 80():231-238. PubMed ID: 29902577
[TBL] [Abstract][Full Text] [Related]
6. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
7. A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes.
Ozawa T; Kandimalla R; Gao F; Nozawa H; Hata K; Nagata H; Okada S; Izumi D; Baba H; Fleshman J; Wang X; Watanabe T; Goel A
Gastroenterology; 2018 Mar; 154(4):844-848.e7. PubMed ID: 29199088
[TBL] [Abstract][Full Text] [Related]
8. Predictors for lymph node metastasis in T1 colorectal cancer.
Suh JH; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Park SC; Park JW; Choi HS; Oh JH
Endoscopy; 2012 Jun; 44(6):590-5. PubMed ID: 22638780
[TBL] [Abstract][Full Text] [Related]
9. Identification and external validation of a novel miRNA signature for lymph node metastasis prediction in submucosal-invasive gastric cancer patients.
Ma M; Lu S; Liu Y; Kong P; Long Z; Wan P; Zhang Y; Wang Y; Xu D
Cancer Med; 2019 Oct; 8(14):6315-6325. PubMed ID: 31486298
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
[TBL] [Abstract][Full Text] [Related]
11. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
12. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
14. Correlation between mitochondrial TRAP-1 expression and lymph node metastasis in colorectal cancer.
Gao JY; Song BR; Peng JJ; Lu YM
World J Gastroenterol; 2012 Nov; 18(41):5965-71. PubMed ID: 23139614
[TBL] [Abstract][Full Text] [Related]
15. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
[TBL] [Abstract][Full Text] [Related]
16. Utility of artificial intelligence with deep learning of hematoxylin and eosin-stained whole slide images to predict lymph node metastasis in T1 colorectal cancer using endoscopically resected specimens; prediction of lymph node metastasis in T1 colorectal cancer.
Song JH; Hong Y; Kim ER; Kim SH; Sohn I
J Gastroenterol; 2022 Sep; 57(9):654-666. PubMed ID: 35802259
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of microRNA Signature in Patients with Gastric Cancers.
Liu HT; Wang YW; Xing AY; Shi DB; Zhang H; Guo XY; Xu J; Gao P
Sci Rep; 2017 Feb; 7():42806. PubMed ID: 28202938
[TBL] [Abstract][Full Text] [Related]
18. Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.
Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Høgdall E; Riis LB
Exp Mol Pathol; 2016 Oct; 101(2):187-196. PubMed ID: 27565378
[TBL] [Abstract][Full Text] [Related]
19. A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.
Zhang L; Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zhao XM
Oncotarget; 2016 Jan; 7(3):3587-98. PubMed ID: 26657296
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers.
Choi YW; Song YS; Lee H; Yi K; Kim YB; Suh KW; Lee D
Medicine (Baltimore); 2016 Apr; 95(15):e3321. PubMed ID: 27082577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
